Maciej L. Goniewicz

PhD, PharmD

Co-Investigator, ITC Four Country, USA

Roswell Park Comprehensive Cancer Center, USA

Dr. Maciej L. Goniewicz joined the staff of Roswell Park Comprehensive Cancer Center (Roswell Park) in 2013 as Assistant Member of the Department of Health Behavior, Division of Cancer Prevention and Population Sciences. In 2016, he was appointed Associate Member and as a Full Member in 2021. He is a Director of the Nicotine and Tobacco Product Assessment Resource (NicoTAR; www.nicotar.org).

He earned a Pharm.D. degree (2002) and a Ph.D. in Toxicology and Pharmacology (2007) from the Medical University of Silesia, Poland. He completed his postdoctoral fellowships in Clinical Pharmacology and Tobacco Control at the University of California San Francisco and in Smoking Cessation Treatment in Queen Mary University of London, UK. 

Dr. Goniewicz has authored over 200 scientific papers on topics related to tobacco control, biomarkers, and nicotine-containing products. His work has been published in NEJM, JAMA, Annals of Internal Medicine, Lancet Respiratory Medicine, Tobacco Control, Nicotine and Tobacco Research, Pediatrics, Chemical Research in Toxicology, Journal of Analytical Toxicology, and Cancer Epidemiology, Biomarkers, and Prevention.

Institution Profile: https://www.roswellpark.org/maciej-goniewicz

Institution Link: https://www.roswellpark.org/